Author: Fanfan Zeng; Chan Dai; Pengcheng Cai; Jinbiao Wang; Lei Xu; Jianyu Li; Guoyun Hu; Lin Wang
Title: A comparison study of SARS-CoV-2 IgG antibody between male and female COVID-19 patients: a possible reason underlying different outcome between gender. Document date: 2020_3_27
ID: a1pa6g5c_34
Snippet: In conclusion, in this study we detected and analyzed the SARS-CoV-2 IgG antibody of 331 patients and found that, compared with male patients, more female patients maintained a high level of IgG antibody after SARS-CoV-2 infection. And the production of IgG in female patients tended to be stronger than male patients in early phase of COVID-19. We propose here that our doctors and nurses should pay more attention to the patients whose IgG antibody.....
Document: In conclusion, in this study we detected and analyzed the SARS-CoV-2 IgG antibody of 331 patients and found that, compared with male patients, more female patients maintained a high level of IgG antibody after SARS-CoV-2 infection. And the production of IgG in female patients tended to be stronger than male patients in early phase of COVID-19. We propose here that our doctors and nurses should pay more attention to the patients whose IgG antibody were at low levels. And monitoring IgG antibody maybe a potential method to assess COVID-19 progression.
Search related documents:
Co phrase search for related documents- attention pay and female patient: 1, 2
- attention pay and high level: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
- attention pay and IgG production: 1
- attention pay and low level: 1, 2, 3, 4, 5, 6, 7, 8, 9
- attention pay and male patient: 1
- attention pay and nurse doctor: 1
- attention pay and potential method: 1, 2
- attention pay and SARS infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31
- attention pay and study detect: 1, 2, 3, 4
- early phase and female patient: 1, 2, 3, 4, 5
- early phase and high level: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39
- early phase and IgG antibody: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15
- early phase and IgG antibody high level: 1, 2, 3, 4
- early phase and IgG production: 1, 2, 3
- early phase and low level: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
- early phase and male patient: 1
- early phase and progression assess: 1, 2
- early phase and SARS infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74
- early phase and study detect: 1, 2
Co phrase search for related documents, hyperlinks ordered by date